Today the incoming is filled with some compelling reviews; considering periodontal inflammation and C.diff with IBD (separately), as well some biopesticide ethics discussion, and mention of exciting biome research mergers and funding afoot. Read on!
Human oral microbiome
Review: Contribution of proteomics to our understanding of periodontal inflammation– Nagihan Bostanci- Proteomics
Human vaginal microbiome
Subclinical alteration of the cervical–vaginal microbiome in women with idiopathic infertility-Giuseppina Campisciano- Journal of Cellular Physiology
Human gut microbiome
Review: Systematic review with meta-analysis: the impact of Clostridium difficile infection on the short and long-term risks of colectomy in inflammatory bowel disease– Law C- Alimentary Pharmacology and Therapeutics
Review: Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered– Yu Qi Qiao- Journal of Digestive Diseases
Fecal microbiota
Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study– Christopher Staley- The American Journal of Gastroenterology
Plant, root, and soil microbiome
Effect of postharvest practices including degreening on citrus carpoplane microbial biomes– Gomba A.- Journal of Applied Microbiology
Biopesticides
Review: Should the biofilm mode of life be taken into consideration for microbial biocontrol agents?– Caroline Pandin- Microbial Biotechnology
http://onlinelibrary.wiley.com/doi/10.1111/1751-7915.12693/full
Microbes in the news
Laundry hygiene—how to get more than clean- Bockmuhl DP- Applied Microbiology
DNA Analysis Reveals Secret Microbiomes in Cities– Paula Solferini Rothman- BU News Service
Microbes on the market
Symbiotix Biotherapies Announces Issuance of First Composition of Matter Patent Covering a Microbiome-derived Therapeutic Molecule– Yahoo Finance
Vedanta Teams with Stanford and Leiden Universities for Microbiome Therapeutics– Genetic Engineering and Biotechnology News
Research Funding
U Of M Commercialization Grants Target Microbiome Test, Sleep Disorders, Epilepsy- Dan Jacobson– Twin Cities Business